20 Healthcare Stocks Moving In Thursday's After-Market Session

 

Gainers

Sonoma Pharmaceuticals, Inc. SNOA stock rose 29.1% to $6.30 during Thursday's after-market session.

Alector, Inc. ALEC shares moved upwards by 10.8% to $25.79. The most recent rating by BTIG, on November 21, is at Buy, with a price target of $28.00.

HTG Molecular Diagnostics, Inc. HTGM shares rose 7.8% to $0.71.

Avadel Pharmaceuticals, Inc. AVDL shares rose 7.6% to $8.10.

Therapix Biosciences, Inc. TRPX shares moved upwards by 6.1% to $0.61.

Rigel Pharmaceuticals, Inc. RIGL shares rose 5.7% to $2.80. The most recent rating by BMO Capital, on December 09, is at Outperform, with a price target of $8.00.

Co-Diagnostics, Inc. CODX shares surged 5.4% to $2.14.

Inovio Pharmaceuticals, Inc. INO stock increased by 5.2% to $4.04. The most recent rating by PiperJaffray, on January 03, is at Overweight, with a price target of $8.00.

Bellicum Pharmaceuticals, Inc. BLCM stock moved upwards by 5.1% to $2.25.

Ritter Pharmaceuticals, Inc. RTTR shares rose 5.0% to $0.20.

Heat Biologics, Inc. HTBX stock moved upwards by 4.5% to $0.30.

Lexicon Pharmaceuticals, Inc. LXRX stock surged 4.2% to $3.59. According to the most recent rating by Gabelli & Co., on December 11, the current rating is at Hold.

NextGen Healthcare, Inc. NXGN stock moved upwards by 3.6% to $16.50. The most recent rating by Wells Fargo, on January 08, is at Underweight, with a price target of $16.00.

 

Losers

Akero Therapeutics, Inc. AKRO shares declined 6.1% to $23.00 during Thursday's after-market session.

AC Immune, Inc. ACIU shares fell 5.1% to $8.78. The most recent rating by H.C. Wainwright, on December 10, is at Buy, with a price target of $11.00.

GNC Holdings, Inc. GNC stock fell 4.0% to $2.14.

Biolase, Inc. BIOL stock plummeted 3.8% to $0.78.

Aquestive Therapeutics, Inc. AQST shares decreased by 3.8% to $3.82. The most recent rating by BMO Capital, on January 13, is at Outperform, with a price target of $18.00.

ContraFect, Inc. CFRX stock decreased by 3.6% to $1.08.

Applied Genetic Tech, Inc. AGTC stock fell 3.5% to $8.08.

Market News and Data brought to you by Benzinga APIs
Posted In: After-Hours CenterMarketsMoversTrading IdeasHealthcare Stocks After-Market MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...